{"id":"W4393238164","doi":"10.1016/j.kint.2024.03.012","title":"A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy","year":2024,"lang":"en","type":"article","venue":"Kidney International","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"BeiGene; International Society of Nephrology; BioCryst; Alnylam Pharmaceuticals; Astellas Pharma; Omeros Corporation; Alexion Pharmaceuticals; AstraZeneca; Argenx; GlaxoSmithKline; Amgen","keywords":"Medicine; Placebo; Double blind; Nephropathy; Randomized controlled trial; Clinical trial; Internal medicine; Endocrinology; Alternative medicine; Diabetes mellitus; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007085822,0.0001857721,0.001165726,0.0002376883,0.00002188836,0.00003094694,0.0001063079,0.00009990686,0.0003869066],"category_scores_gemma":[0.001108835,0.0001216369,0.001576958,0.00009661755,0.0001908087,0.0000903997,0.00002134279,0.00006123264,0.00002036404],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006449225,"about_ca_system_score_gemma":0.0005499966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003713935,"about_ca_topic_score_gemma":0.000001622232,"domain_scores_codex":[0.9978536,0.00008651292,0.00119848,0.0002940669,0.0004193577,0.0001479437],"domain_scores_gemma":[0.9980839,0.0009268061,0.0002601762,0.0002015913,0.0002734088,0.0002540488],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9703441,0.004025541,0.0000292065,0.0001947863,0.002733669,0.0000309928,0.0001861507,0.000003018733,0.0002807892,0.0046235,0.00723316,0.01031503],"study_design_scores_gemma":[0.9446334,0.004542974,0.000004004875,0.0002899647,0.001597499,0.00001450241,0.00004247919,0.006463157,0.0008150447,0.0003673026,0.04113669,0.00009304331],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.945652,0.004425725,0.005330628,0.01095758,0.008141223,0.01248946,0.002560439,0.0001480457,0.01029489],"genre_scores_gemma":[0.9898062,0.001289296,0.0009058297,0.0002600758,0.002253167,0.001244387,0.0007719956,0.00002920541,0.003439891],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04415415,"threshold_uncertainty_score":0.4960209,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06695141830526719,"score_gpt":0.4256853226899625,"score_spread":0.3587339043846953,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}